Biomerica Stock Performance
| BMRA Stock | USD 0.39 0.07 21.88% |
The firm shows a Beta (market volatility) of 2.03, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomerica will likely underperform. Biomerica right now shows a risk of 6.34%. Please confirm Biomerica maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Biomerica will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biomerica has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Biomerica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:2 | Last Split Date 1994-11-14 |
1 | Biomerica Announces Direct-to-Consumer Availability of inFoods IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain | 10/30/2024 |
2 | Granahan Investment Management Reduces Stake in Biomerica Inc | 11/15/2024 |
| Begin Period Cash Flow | 9.7 M |
Biomerica |
Biomerica Relative Risk vs. Return Landscape
If you would invest 43.00 in Biomerica on September 3, 2024 and sell it today you would lose (4.00) from holding Biomerica or give up 9.3% of portfolio value over 90 days. Biomerica is currently generating 0.0386% in daily expected returns and assumes 6.3414% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than Biomerica, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biomerica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomerica's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomerica, and traders can use it to determine the average amount a Biomerica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BMRA |
Estimated Market Risk
| 6.34 actual daily | 56 56% of assets are less volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biomerica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomerica by adding Biomerica to a well-diversified portfolio.
Biomerica Fundamentals Growth
Biomerica Stock prices reflect investors' perceptions of the future prospects and financial health of Biomerica, and Biomerica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomerica Stock performance.
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.39 | ||||
| Profit Margin | (1.12) % | ||||
| Operating Margin | (0.76) % | ||||
| Current Valuation | 4.44 M | ||||
| Shares Outstanding | 16.82 M | ||||
| Price To Earning | (25.64) X | ||||
| Price To Book | 1.23 X | ||||
| Price To Sales | 1.19 X | ||||
| Revenue | 5.42 M | ||||
| Gross Profit | 446 K | ||||
| EBITDA | (5.99 M) | ||||
| Net Income | (5.98 M) | ||||
| Cash And Equivalents | 6.08 M | ||||
| Cash Per Share | 0.45 X | ||||
| Total Debt | 785 K | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.22 X | ||||
| Book Value Per Share | 0.32 X | ||||
| Cash Flow From Operations | (5.36 M) | ||||
| Earnings Per Share | (0.37) X | ||||
| Market Capitalization | 5.46 M | ||||
| Total Asset | 9.25 M | ||||
| Retained Earnings | (48.2 M) | ||||
| Working Capital | 5.53 M | ||||
| Current Asset | 4.77 M | ||||
| Current Liabilities | 445 K | ||||
About Biomerica Performance
By analyzing Biomerica's fundamental ratios, stakeholders can gain valuable insights into Biomerica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomerica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomerica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 180.52 | 138.54 | |
| Return On Tangible Assets | (0.66) | (0.63) | |
| Return On Capital Employed | (0.90) | (0.86) | |
| Return On Assets | (0.65) | (0.61) | |
| Return On Equity | (0.91) | (0.86) |
Things to note about Biomerica performance evaluation
Checking the ongoing alerts about Biomerica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomerica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomerica had very high historical volatility over the last 90 days | |
| Biomerica has some characteristics of a very speculative penny stock | |
| Biomerica has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 5.42 M. Net Loss for the year was (5.98 M) with profit before overhead, payroll, taxes, and interest of 446 K. | |
| Biomerica currently holds about 6.08 M in cash with (5.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: Granahan Investment Management Reduces Stake in Biomerica Inc |
- Analyzing Biomerica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomerica's stock is overvalued or undervalued compared to its peers.
- Examining Biomerica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomerica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomerica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomerica's stock. These opinions can provide insight into Biomerica's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |